HeartSciences Inc. $HSCS
Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.
Snapshot
- Exchange
- Nasdaq Capital Market
- Sector
- Finance Services
- Headquarters
- Southlake, TX
- Fiscal year end
- April 30
- Shares outstanding
- 4,800,172 [10-Q 2026-09-14]
What the company doesAI summary of filing
HeartSciences Inc. is a healthcare information technology company that develops and commercializes electrocardiography (ECG) software and devices integrated with artificial intelligence algorithms. The company's primary product is MyoVista Insights™, a cloud-based ECG management platform classified as a Medical Device Data System that is exempt from FDA 510(k) clearance and designed to streamline ECG workflows and host multiple AI-ECG algorithms. The company also develops the MyoVista wavECG device, a 12-lead ECG system that was submitted to the FDA for 510(k) clearance in December 2025 and remains under review. HeartSciences is pre-revenue, expects to generate revenue from software installation fees, SaaS usage fees, and marketplace fees for AI-ECG algorithms, and will require additional funding for continued development and commercialization. [10-K 2026-07-23]
Financial health
| Period | Revenue | Net income | Operating cash flow | Cash | Filing |
|---|---|---|---|---|---|
| 3 months to Jul 2026 | $2.1K | −$3.17M | −$1.32M | $29.9K | [10-Q 2026-09-14] |
| FY ended Apr 2026 | $4.3K | −$9.14M | −$7.43M | $1.66M | [10-K 2026-07-23] |
| FY ended Apr 2025 | $4.3K | −$8.77M | −$7.41M | $1.10M | [10-K 2026-07-23] |
- Quarterly cash burn
- −$1.32M
- Cash runway Estimate
- ~0.1 months
Capital structure and dilution
| Date | Shares outstanding | Filing |
|---|---|---|
| 2024-12-12 | 980,321 | [10-Q 2024-12-16] |
| 2025-03-12 | 1,080,946 | [10-Q 2025-03-13] |
| 2025-07-23 | 1,934,280 | [10-K 2025-07-24] |
| 2025-09-10 | 2,647,712 | [10-Q 2025-09-11] |
| 2025-12-12 | 3,178,207 | [10-Q 2025-12-15] |
| 2026-03-16 | 3,184,700 | [10-Q 2026-03-16] |
| 2026-07-20 | 3,899,491 | [10-K 2026-07-23] |
| 2026-09-11 | 4,800,172 | [10-Q 2026-09-14] |
- Shelf registration
- S-3 filed 2026-09-25; no effectiveness notice found in EDGAR [S-3 2026-09-25]
Listing status
Current status: 4 Form 8-K Item 3.01 filing(s) in the last 24 months, most recent 2026-08-07. Item 3.01 covers delisting notices, failures to meet a listing rule and listing transfers; read the filing for which one.
| Date | Event | Details | Deadline | Filing |
|---|---|---|---|---|
| 2026-08-07 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2026-08-07] |
| 2025-09-17 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2025-09-17] |
| 2025-05-19 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2025-05-19] |
| 2025-03-21 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2025-03-21] |
Who owns it
| Date | Insider | Type | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-06-22 | Simpson Andrew | grant | 425,000 | — | [4 2026-06-24] |
| 2025-11-28 | Simpson Andrew | grant | 70,000 | — | [4 2025-11-28] |
Catalysts and calendar
| Date | Type | Title |
|---|---|---|
| 2026-10-09 | 424B5 | Prospectus or prospectus supplement |
| 2026-10-06 | 8-K | Regulation FD disclosure |
| 2026-10-02 | 8-K | Material agreement entered; New financial obligation |
| 2026-09-25 | S-3 | Registration statement |
| 2026-09-17 | 8-K | Regulation FD disclosure; Other events |
| 2026-09-15 | 8-K | Results of operations |
| 2026-09-14 | 10-Q | Quarterly report |
| 2026-08-20 | 8-K | Regulation FD disclosure |
| 2026-08-19 | 8-K | Regulation FD disclosure |
| 2026-08-18 | 13D | Beneficial ownership report (5%+ holder) |
| 2026-08-18 | 8-K | Material agreement entered; Unregistered sale of equity |
| 2026-08-07 | 8-K | Listing notice or transfer |
Alerts for $HSCS
Email me when HeartSciences Inc. files an offering, gets a deficiency notice, or moves sharply.
Facts as of . Small caps move fast; check the latest filings.